[HTML][HTML] Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside
Acinetobacter baumannii (A. baumannii) is undoubtedly one of the most successful
pathogens in the modern healthcare system. With invasive procedures, antibiotic use and …
pathogens in the modern healthcare system. With invasive procedures, antibiotic use and …
Small, Enigmatic Plasmids of the Nosocomial Pathogen, Acinetobacter baumannii: Good, Bad, Who Knows?
Acinetobacter baumannii is a Gram-negative nosocomial pathogen that has become a
serious healthcare concern within a span of two decades due to its ability to rapidly acquire …
serious healthcare concern within a span of two decades due to its ability to rapidly acquire …
Variation in the Complex Carbohydrate Biosynthesis Loci of Acinetobacter baumannii Genomes
Extracellular polysaccharides are major immunogenic components of the bacterial cell
envelope. However, little is known about their biosynthesis in the genus Acinetobacter …
envelope. However, little is known about their biosynthesis in the genus Acinetobacter …
New insights into dissemination and variation of the health care-associated pathogen Acinetobacter baumannii from genomic analysis
Acinetobacter baumannii is a globally important nosocomial pathogen characterized by an
increasing incidence of multidrug resistance. Routes of dissemination and gene flow among …
increasing incidence of multidrug resistance. Routes of dissemination and gene flow among …
Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China
Carbapenem-resistant Acinetobacter baumannii has spread rapidly across China and is
currently reported to be a worldwide nosocomial menace. In light of its increasing clinical …
currently reported to be a worldwide nosocomial menace. In light of its increasing clinical …
Comparative genomic analysis of Acinetobacter baumannii clinical isolates reveals extensive genomic variation and diverse antibiotic resistance determinants
Background Acinetobacter baumannii is an important nosocomial pathogen that poses a
serious health threat to immune-compromised patients. Due to its rapid ability to develop …
serious health threat to immune-compromised patients. Due to its rapid ability to develop …
Novel aminoglycoside resistance transposons and transposon-derived circular forms detected in carbapenem-resistant Acinetobacter baumannii clinical isolates
N Karah, CK Dwibedi, K Sjöström… - Antimicrobial agents …, 2016 - Am Soc Microbiol
Acinetobacter baumannii has emerged as an important opportunistic pathogen equipped
with a growing number of antibiotic resistance genes. Our study investigated the molecular …
with a growing number of antibiotic resistance genes. Our study investigated the molecular …
Evolution of AbGRI2-0, the progenitor of the AbGRI2 resistance island in global clone 2 of Acinetobacter baumannii
ABSTRACT A320, isolated in the Netherlands in 1982 and also known as RUH134, is the
earliest available multiply antibiotic-resistant (MAR) Acinetobacter baumannii isolate …
earliest available multiply antibiotic-resistant (MAR) Acinetobacter baumannii isolate …
Loss and gain of aminoglycoside resistance in global clone 2 Acinetobacter baumannii in Australia via modification of genomic resistance islands and acquisition of …
Objectives The objective of this study was to examine the evolution of carbapenem-resistant
global clone 2 (GC2) Acinetobacter baumannii in Australia focusing on the complement of …
global clone 2 (GC2) Acinetobacter baumannii in Australia focusing on the complement of …
Dissemination of clonal complex 2 Acinetobacter baumannii strains co-producing carbapenemases and 16S rRNA methylase ArmA in Vietnam
T Tada, T Miyoshi-Akiyama, K Shimada, TTT Nga… - BMC Infectious …, 2015 - Springer
Background Acinetobacter baumannii strains co-producing carbapenemase and 16S rRNA
methylase are highly resistant to carbapenems and aminoglycosides. Methods Ninety-three …
methylase are highly resistant to carbapenems and aminoglycosides. Methods Ninety-three …